Retinitis Pigmentosa News and Research

RSS
Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Photoreceptor cells capture and process light helping us to see. As these cells breakdown and die, patients experience progressive vision loss. The most common feature of all forms of RP is a gradual breakdown of rods (retinal cells that detect dim light) and cones (retinal cells that detect light and color). Most forms of RP first cause the breakdown of rod cells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness. Night blindness is somewhat like the experience normally sighted individuals encounter when entering a dark movie theatre on a bright, sunny day. However, patients with RP cannot adjust well to dark and dimly lit environments.
New Mechanism for Precise Protein Production Unveiled

New Mechanism for Precise Protein Production Unveiled

Researchers Provide Genetic Diagnosis for 30 Long-Term Undiagnosed Cases

Researchers Provide Genetic Diagnosis for 30 Long-Term Undiagnosed Cases

Developing DNA Test to Eliminate Inherited Blindness in English Shepherd Dogs

Developing DNA Test to Eliminate Inherited Blindness in English Shepherd Dogs

Study Unveils Dual Role of 7-DHC in Ferroptosis and Cancer Cell Survival

Study Unveils Dual Role of 7-DHC in Ferroptosis and Cancer Cell Survival

LambdaVision Aims to Refine Process for In-Space Manufacturing of Artificial Retinas Through ISS National Lab-Sponsored Investigation

LambdaVision Aims to Refine Process for In-Space Manufacturing of Artificial Retinas Through ISS National Lab-Sponsored Investigation

Review: Role of Alternative Splicing Defects in Major Neurodegenerative Diseases

Review: Role of Alternative Splicing Defects in Major Neurodegenerative Diseases

Engineered Sustainable, Patient-Specific NPCs Could Help Treat Neurodegenerative Diseases

Engineered Sustainable, Patient-Specific NPCs Could Help Treat Neurodegenerative Diseases

UH Researcher Designs New Model Expressing the Most Common Disease Mutation in USH2A

UH Researcher Designs New Model Expressing the Most Common Disease Mutation in USH2A

Next-Generation Sequencing Provides New Insights into Mutations of Mitochondrial DNA

Next-Generation Sequencing Provides New Insights into Mutations of Mitochondrial DNA

Genome editing proven effective to restore the vision of mice with genetic diseases

Genome editing proven effective to restore the vision of mice with genetic diseases

Discovery of a new cellular element crucial to sense of smell

Discovery of a new cellular element crucial to sense of smell

3D “mini eyes” provide insight into genetically induced blindness

3D “mini eyes” provide insight into genetically induced blindness

New tool advances potential means to deliver gene therapy

New tool advances potential means to deliver gene therapy

Researchers discover the gene essential for the growth of photoreceptors

Researchers discover the gene essential for the growth of photoreceptors

Cryo-ET reveals mechanisms underlying gene mutations that lead to blindness

Cryo-ET reveals mechanisms underlying gene mutations that lead to blindness

Researchers identify production mechanism of light-sensitive protein of photoreceptors

Researchers identify production mechanism of light-sensitive protein of photoreceptors

'Switching on' Sight using Gene Therapy

'Switching on' Sight using Gene Therapy

Study uncovers new gene variants that may cause inherited retinal dystrophies

Study uncovers new gene variants that may cause inherited retinal dystrophies

Gene therapy protects eye cells in mice with retinitis pigmentosa

Gene therapy protects eye cells in mice with retinitis pigmentosa

Multidisciplinary approaches for data management in omics research

Multidisciplinary approaches for data management in omics research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.